Skip to content

Drug interactions

Arformoterol + Propafenone

Severity: Moderate

Arformoterol and Propafenone: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Arformoterol, a long-acting beta-agonist, can cause hypokalemia, tachycardia and QT prolongation, which may add to propafenone's proarrhythmic potential. Risk is greater in patients with heart disease or electrolyte disturbances.

What this interaction means in plain words

Arformoterol and Propafenone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Arformoterol belongs to Respiratory; Propafenone belongs to Cardiovascular.

Evidence level: Low

Why it happens

Additive proarrhythmic effects from beta-agonist induced hypokalemia and QT prolongation with propafenone's conduction effects.

What to do

Monitor ECG, heart rate and serum potassium during co-therapy. Correct hypokalemia promptly.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Arformoterol and Propafenone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Arformoterol with Propafenone?

MediHelp rates the interaction as moderate. Arformoterol and Propafenone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Arformoterol, a long-acting beta-agonist, can cause hypokalemia, tachycardia and QT prolongation, which may add to propafenone's proarrhythmic potential. Risk is greater in patients with heart disease or electrolyte disturbances.

How serious is the interaction between Arformoterol and Propafenone?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor ECG, heart rate and serum potassium during co-therapy. Correct hypokalemia promptly.

What other medicines interact with Propafenone?

MediHelp also lists interactions of Propafenone with, for example, Dofetilide, Dronedarone, Nilotinib. The full list is on the Propafenone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in